OncoSil wraps up recruitment for key pancreatic cancer trial
Pancreatic cancer treatment focused OncoSil Medical's (ASX:OSL) shares stayed flat on Friday as the company revealed it had finally...
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online